{"prompt": "['pembrolizumab and administer corticosteroids. Dose modification and toxicity management', 'guidelines for irAEs associated with pembrolizumab are provided in Table 6.', 'As this is a neoadjuvant study culminating in the potentially curative surgery, we will allow no', 'more than one dose-limiting toxicity for each drug including lenvatinib and pembrolizumab. Any', 'more than one dose-limiting toxicity for each drug will result in discontinuation of both study', 'drugs and early nephrectomy at least 7 days after the last dose of lenvatinib. Those patients will', 'be in-evaluable and be replaced.', 'Page 25', 'Version Date: 02/09/2020']['Table 6. Dose Modification and Toxicity Management Guidelines for Immune-Related AEs Associated with Pembrolizumab', 'General instructions:', '1. Corticosteroid taper should be initiated upon AE improving to Grade 1 or less and continue to taper over at least 4 weeks.', '2. For situations where pembrolizumab has been withheld, pembrolizumab can be resumed after AE has been reduced to Grade 1 or 0 and', 'corticosteroid has been tapered. Pembrolizumab should be permanently discontinued if AE does not resolve within 12 weeks of last dose or', 'corticosteroids cannot be reduced to 10 mg prednisone or equivalent per day within 12 weeks.', '3. For severe and life-threatening irAEs, IV corticosteroid should be initiated first followed by oral steroid. Other immunosuppressive treatment', 'should be initiated if irAEs cannot be controlled by corticosteroids.', 'Immune-related', 'Toxicity grade or', 'Action taken to', 'irAE management with', 'Monitor and follow-up', 'AEs', 'conditions', 'pembrolizumab', 'corticosteroid and/or other', '(CTCAEv4.0)', 'therapies', 'Pneumonitis', 'Grade 2', 'Withhold', 'Administer corticosteroids (initial', 'Monitor participants for signs and', 'dose of 1-2 mg/kg prednisone or', 'symptoms of pneumonitis', 'equivalent) followed by taper', 'Evaluate participants with suspected', 'Grade 3 or 4, or', 'Permanently', 'pneumonitis with radiographic imaging and', 'initiate corticosteroid treatment', 'recurrent Grade 2', 'discontinue', 'Add prophylactic antibiotics for', 'opportunistic infections', 'Diarrhea / Colitis', 'Grade 2 or 3', 'Withhold', 'Administer corticosteroids (initial', 'Monitor participants for signs and symptoms', 'dose of 1-2 mg/kg prednisone or', 'of enterocolitis (i.e., diarrhea, abdominal', 'equivalent) followed by taper', 'pain, blood or mucus in stool with or', 'without fever) and of bowel perforation', '(i.e., peritoneal signs and ileus).', 'Participants with > Grade 2 diarrhea', 'Grade 4', 'Permanently', 'suspecting colitis should consider GI', 'discontinue', 'consultation and performing endoscopy to', 'rule out colitis.', 'Participants with diarrhea/colitis should be', 'advised to drink liberal quantities of clear', 'fluids. If sufficient oral fluid intake is not', 'feasible, fluid and electrolytes should be', 'substituted via IV infusion.', '26']['AST / ALT', 'Grade 2', 'Withhold', 'Administer corticosteroids (initial', 'Monitor with liver function tests (consider', 'elevation or', 'dose of 0.5- 1 mg/kg prednisone or', 'weekly or more frequently until liver', 'Increased', 'equivalent) followed by taper', 'enzyme value returned to baseline or is', 'bilirubin', 'Grade 3 or 4', 'Permanently', 'Administer corticosteroids (initial', 'stable', 'discontinue', 'dose of 1-2 mg/kg prednisone or', 'equivalent) followed by taper', 'Type 1 diabetes', 'Newly onset', 'Withhold', 'Initiate insulin replacement', 'Monitor participants for hyperglycemia or', 'mellitus (T1DM)', 'T1DM or', 'therapy for participants with', 'other signs and symptoms of diabetes.', 'or', 'Grade 3 or 4', 'T1DM', 'Hyperglycemia', 'hyperglycemia', 'Administer anti-hyperglycemic in', 'associated with', 'participants with hyperglycemia', 'evidence of \u00df-cell', 'failure', 'Hypophysitis', 'Grade 2', 'Withhold', 'Administer corticosteroids and', 'Monitor for signs and symptoms of', 'initiate hormonal replacements as', 'hypophysitis (including hypopituitarism and', 'clinically indicated.', 'adrenal insufficiency)', 'Grade 3 or 4', 'Withhold or', 'permanently', 'discontinue\u00b9', 'Hyperthyroidism', 'Grade 2', 'Continue', 'Treat with non-selective beta-', 'Monitor for signs and symptoms of thyroid', 'blockers (e.g., propranolol) or', 'disorders.', 'thionamides as appropriate', 'Grade 3 or 4', 'Withhold or', 'permanently', 'discontinue\u00b9', 'Hypothyroidism', 'Grade 2-4', 'Continue', 'Initiate thyroid replacement', 'Monitor for signs and symptoms of thyroid', 'hormones (e.g., levothyroxine or', 'disorders.', 'liothyroinine) per standard of care', 'Nephritis and', 'Grade 2', 'Withhold', 'Administer corticosteroids', 'Monitor changes of renal function', 'Renal', '(prednisone 1-2 mg/kg or', 'dysfunction', 'Grade 3 or 4', 'Permanently', 'equivalent) followed by taper.', 'discontinue', 'Myocarditis', 'Grade 1 or 2', 'Withhold', 'Based on severity of AE', 'Ensure adequate evaluation to confirm', 'administer corticosteroids', 'etiology and/or exclude other causes', 'Grade 3 or 4', 'Permanently', 'discontinue', '27']\n\n###\n\n", "completion": "END"}